- Home
- ATPC vs MYNZ Comparison
ATPC vs MYNZ Comparison
Compare ATPC & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATPC
- MYNZ
- Stock Information
- Founded
- ATPC 2016
- MYNZ 2021
- Country
- ATPC Malaysia
- MYNZ Germany
- Employees
- ATPC N/A
- MYNZ N/A
- Industry
- ATPC Medical/Nursing Services
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- ATPC Health Care
- MYNZ Health Care
- Exchange
- ATPC Nasdaq
- MYNZ Nasdaq
- Market Cap
- ATPC 5.7M
- MYNZ 6.1M
- IPO Year
- ATPC N/A
- MYNZ 2021
- Fundamental
- Price
- ATPC $1.45
- MYNZ $0.24
- Analyst Decision
- ATPC
- MYNZ Buy
- Analyst Count
- ATPC 0
- MYNZ 2
- Target Price
- ATPC N/A
- MYNZ $3.00
- AVG Volume (30 Days)
- ATPC 257.4K
- MYNZ 5.2M
- Earning Date
- ATPC 11-14-2024
- MYNZ 11-26-2024
- Dividend Yield
- ATPC N/A
- MYNZ N/A
- EPS Growth
- ATPC N/A
- MYNZ N/A
- EPS
- ATPC N/A
- MYNZ N/A
- Revenue
- ATPC $1,354,042.00
- MYNZ $917,203.00
- Revenue This Year
- ATPC N/A
- MYNZ $36.69
- Revenue Next Year
- ATPC N/A
- MYNZ $91.67
- P/E Ratio
- ATPC N/A
- MYNZ N/A
- Revenue Growth
- ATPC N/A
- MYNZ 16.23
- 52 Week Low
- ATPC $1.36
- MYNZ $0.19
- 52 Week High
- ATPC $24.60
- MYNZ $1.79
- Technical
- Relative Strength Index (RSI)
- ATPC 40.67
- MYNZ 45.71
- Support Level
- ATPC $1.61
- MYNZ $0.22
- Resistance Level
- ATPC $1.53
- MYNZ $0.36
- Average True Range (ATR)
- ATPC 0.13
- MYNZ 0.04
- MACD
- ATPC -0.01
- MYNZ 0.00
- Stochastic Oscillator
- ATPC 7.14
- MYNZ 18.59
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.